.view-toggle-wrapper { display: none; } #content-overview { display: block !important; } #content-technical { display: block !important; margin-top: 50px; border-top: 2px solid #ccc; padding-top: 30px; }

Use the toggle to switch between the simple Overview and the Technical Data content.

Betaine Anhydrous (TMG): Uses, Evidence, and Safety

Overview

Plain-English information for everyday use

1. What Is Betaine (TMG)?

Key Takeaway

Betaine — also called trimethylglycine or TMG — is a natural compound from foods like beets that acts as a "methyl donor." The same molecule is also a prescription medicine for a rare inherited condition, but that's a separate, supervised use.

Betaine (trimethylglycine, or TMG) is a small natural molecule found in foods such as beets, spinach, and whole grains, and also made in your body from choline. It has two main jobs: it acts as a methyl donor (handing off a chemical "methyl" group, which helps recycle a substance called homocysteine), and it works as an osmolyte — a compound that helps cells manage water balance. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗

An important distinction. The supplement sold as "betaine anhydrous" or "TMG" is the same molecule that is also an FDA-approved prescription medicine (under the name Cystadane) for a rare inherited condition called homocystinuria. That medical use involves much higher doses and close monitoring by a specialist — it is not what a dietary supplement is for, and this page is about the supplement. U.S. Food and Drug Administration. Cystadane (betaine anhydrous) Prescribing Information. Open Source ↗

One more note on forms: betaine anhydrous (TMG) is the systemic methyl-donor form discussed here. Betaine HCl is a different, acidic form used as a digestive aid for low stomach acid — a separate purpose. LiverTox (NIH). Betaine. Open Source ↗

Key Highlights

A natural "methyl donor" from foods like beets; also made from choline
Reliably lowers homocysteine, a substance measured on blood tests
The same molecule is a prescription medicine for a rare inherited condition (a separate, supervised use)
As a supplement, the popular uses (muscle, liver, heart) are weakly supported or unproven (Section 6)
Important: high doses can raise LDL cholesterol and triglycerides (Section 5)
Generally well tolerated at usual supplement doses, and not linked to liver injury

2. Why People Take It

Key Takeaway

Betaine reliably lowers a blood marker (homocysteine), which is why it's marketed for the heart, muscle, and liver. But lowering a marker isn't the same as a proven health benefit — and for most of these uses, the human evidence is weak or negative.

People take betaine (TMG) for several reasons. Here's an honest look at how the evidence actually stacks up: Nikrandt G, Chmurzynska A. J Nutr. 2024. Open Source ↗

Lowering homocysteine — betaine genuinely does this (it's a blood marker), but lowering it has not been shown to reduce heart events.
Muscle, strength, and body composition — a pooled analysis of trials found no benefit for body composition; strength effects are small and inconsistent.
Liver support — a well-run human trial was negative, despite promising animal studies.
Heart health — not proven, and (importantly) high doses can raise cholesterol and triglycerides.

A reality check: feeling tired or "under-methylated" is not specific — it can have many different causes, and no single nutrient taken alone is a fix. Betaine is a dietary supplement, not a remedy for any specific health problem, and it is not a substitute for the prescription medicine. The most reliable thing it does — lowering homocysteine — hasn't translated into a proven outcome benefit. Talk to your healthcare provider about persistent symptoms or before using betaine to influence a lab value.

3. Who Should Be Careful

Key Takeaway

The main supplement-dose caution is the cholesterol/triglyceride rise at high doses — especially relevant if heart health is your goal. A true allergy to betaine is the one absolute reason to avoid it.

Talk with your healthcare provider before using betaine (TMG) if you:

Are watching your cholesterol or triglycerides. Higher doses (around 4–6 g/day and up) can raise LDL cholesterol and triglycerides — counterproductive if heart health is the goal. Olthof MR, et al. Effect of betaine on blood lipids. Open Source ↗
Have reduced kidney or liver function. Betaine handling changes in these situations, so use only with guidance. LiverTox (NIH). Betaine. Open Source ↗
Take vigabatrin or amino-acid mixtures. Product information advises leaving about 30 minutes between betaine and these, since they may compete for the same transporter. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗
Are a competitive athlete. Because betaine is made from sugar beet, beet-derived products can occasionally be contaminated with a banned substance (higenamine) — choose third-party-tested products. EFSA NDA Panel. Safety of betaine as a novel food. Open Source ↗
Have a known allergy to betaine. Hypersensitivity is the one absolute reason to avoid it. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

If you have the rare inherited condition betaine is approved to treat, that is a supervised medical situation — use the prescription medicine your specialist provides and follow their monitoring, not an over-the-counter supplement.

If You're Pregnant or Breastfeeding

P-3 — Insufficient data (precautionary) Breast-milk transfer: T-U (unstudied)

Betaine occurs naturally in the body and in food, and small dietary amounts are part of a normal diet. But supplement-level doses have not been studied in pregnancy, so a precautionary approach is appropriate — don't start a betaine supplement in pregnancy without your obstetric provider's input. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

For breastfeeding, betaine is naturally present in breast milk, but the safety of supplementing while nursing is essentially unstudied. Discuss it with a lactation consultant or your pediatrician, and you can ask them to check the LactMed database. Centers for Disease Control and Prevention. Breastfeeding & Medications. Open Source ↗

Discontinue and Seek Medical Attention If:

You have an allergic reaction (rash, welts, swelling, or trouble breathing).
You develop persistent stomach upset or a bothersome fishy body odor — usually a sign the dose is too high.
A cholesterol/triglyceride check worsens while you're taking higher doses.
For any large accidental overdose, contact Poison Control (1-800-222-1222).

4. Using It Sensibly

Key Takeaway

If you use it, keep the dose modest (around 2.5 g/day is what sports studies used) — and remember that pushing the dose higher to chase a benefit can backfire on your cholesterol.

Practical Tips

Keep the dose modest. Sports studies typically used about 2.5 g/day; homocysteine-lowering has been studied at roughly 1.5–6 g/day. More is not better. EFSA NDA Panel. Safety of betaine as a novel food. Open Source ↗
Don't chase benefits with high doses. Pushing toward gram-level doses raises the chance of a cholesterol/triglyceride rise without a proven payoff. Olthof MR, et al. Effect of betaine on blood lipids. Open Source ↗
Food counts too. Beets, spinach, and whole grains supply betaine naturally (Section 7).
Dissolve and take with fluid. The powder is bitter; mix it in water or juice. It also absorbs moisture, so keep it sealed and dry. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗
It's not a muscle-builder. If lean mass is your goal, the evidence doesn't support betaine for that. Ashtary-Larky D, et al. Br J Nutr. 2022. Open Source ↗

5. Side Effects

Key Takeaway

At usual supplement doses betaine is generally well tolerated — mostly mild stomach upset and a possible fishy body odor. The stand-out concern is that high doses can raise cholesterol and triglycerides. Reassuringly, betaine is not linked to liver injury.

At the typical supplement dose (around 2.5 g/day), betaine is generally very well tolerated. Side effects are dose-related: LiverTox (NIH). Betaine. Open Source ↗

Stomach upset — nausea, loose stools, bloating, or cramps, mostly at higher doses (the most common complaint).
A mild fishy body or breath odor — related to how betaine is processed.
Raised cholesterol and triglycerides — seen at higher doses (around 4–6 g/day), which is the main reason to keep the dose modest.
Less common: welts or hair loss have been reported.

Two reassuring points. First, betaine is not associated with liver injury. Second, the one serious risk you may read about — brain swelling from very high methionine levels — has occurred only in patients taking the high-dose prescription medicine for the rare inherited condition, and it resolves when the medicine is stopped. It is not a concern at supplement doses. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

6. What Research Suggests

Key Takeaway

Betaine clearly lowers homocysteine. Beyond that, the popular claims don't hold up well: no body-composition benefit in pooled trials, a negative liver trial, and no proven heart-outcome benefit — plus a cholesterol-raising signal at high doses.

Homocysteine — it works on the marker. Betaine supplementation lowers plasma homocysteine in a dose-dependent way. This is its most reliable effect. The catch: lowering homocysteine has not, by itself, been shown to reduce heart events. McRae MP. Betaine and plasma homocysteine: a meta-analysis. Open Source ↗

Muscle and body composition — not supported. A systematic review and meta-analysis concluded that betaine fails to improve body composition — no change in body mass, fat mass, or lean mass. Individual trials are mixed; any strength effect is small and inconsistent. Ashtary-Larky D, et al. Br J Nutr. 2022. Open Source ↗ Cholewa JM, et al. J Int Soc Sports Nutr. 2018. Open Source ↗

Liver — a negative human trial. Despite encouraging animal studies, a year-long, placebo-controlled trial in people with confirmed liver fat found no meaningful improvement over placebo. The researchers themselves cautioned that animal results may not translate to humans. Abdelmalek MF, et al. Betaine for liver fat: a randomized placebo-controlled trial. Hepatology. 2009. Open Source ↗

Heart and metabolism — unproven, with a lipid caveat. Betaine lowers homocysteine but has not been shown to lower cardiovascular risk; meanwhile, at higher doses it can raise LDL cholesterol and triglycerides. A critical review summarized the situation bluntly: the marketing has outpaced the evidence. Nikrandt G, Chmurzynska A. J Nutr. 2024. Open Source ↗

7. Food Sources

Key Takeaway

Beets gave betaine its name. It's also in spinach, whole grains, quinoa, seafood, and legumes. There's no official daily requirement — betaine isn't classed as an essential nutrient.

Food	Serving	Betaine (approx.)
Wheat bran	100 g	1339 mg
Wheat germ	100 g	1241 mg
Spinach	100 g	645 mg
Pretzels	100 g	237 mg
Shrimp	100 g	218 mg
Wheat bread	100 g	201 mg
Beets (beetroot)	100 g	~130 mg

Betaine is widespread in food. The richest sources are beets and beetroot (the original source), along with spinach, wheat bran and wheat germ, whole-grain cereals, quinoa, shellfish and other seafood, and legumes. Typical dietary intake is roughly 100–400 mg per day. Zeisel SH, et al. Concentrations of betaine in common foods. Open Source ↗

Unlike vitamins, betaine is not classified as an essential nutrient — there's no defined deficiency state and no recommended daily intake. Your body can also make it from choline. LiverTox (NIH). Betaine. Open Source ↗

8. Body Systems It Touches

Key Takeaway

Betaine is mainly active in the kidney (water balance) and the liver (methyl chemistry). It influences blood markers — lowering homocysteine, but nudging cholesterol up at high doses.

The systems betaine is involved in include:

The kidneys. Betaine is a major "osmolyte" in the kidney, helping cells there manage water and salt balance. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗
The liver. The liver is where betaine does most of its methyl-donor work — though, as above, a human trial for liver fat was negative. Obeid R. The metabolic burden of methyl-donor deficiency. Open Source ↗
Blood and heart. Betaine lowers homocysteine but can raise cholesterol and triglycerides at high doses — a mixed picture. Olthof MR, et al. Effect of betaine on blood lipids. Open Source ↗

These are general, structure-and-function roles — these are not medical claims about these systems.

9. Frequently Asked Questions

Is TMG the same as betaine HCl?

They share the betaine molecule but serve different purposes. TMG (betaine anhydrous) is the neutral, methyl-donor form discussed here. Betaine HCl is an acidic form used as a digestive aid for low stomach acid — a separate use. LiverTox (NIH). Betaine. Open Source ↗

Is the supplement the same as the prescription drug?

It's the same molecule, but they aren't interchangeable. The prescription medicine (Cystadane) is used at much higher doses, under specialist monitoring, for a rare inherited condition. A supplement is not a substitute for prescribed care for that condition, and shouldn't be used as a stand-in for it. U.S. Food and Drug Administration. Cystadane (betaine anhydrous) Prescribing Information. Open Source ↗

Will betaine help me build muscle?

The evidence doesn't support it. A pooled analysis of trials found no benefit for body composition, and strength effects are small and inconsistent. Ashtary-Larky D, et al. Br J Nutr. 2022. Open Source ↗

Does betaine help the liver?

Animal studies looked promising, but a year-long human trial was negative. So betaine isn't a supported option for liver fat in people. Abdelmalek MF, et al. Betaine for liver fat: a randomized placebo-controlled trial. Hepatology. 2009. Open Source ↗

It lowers homocysteine — doesn't that protect my heart?

Lowering homocysteine is a marker effect; it hasn't been shown to reduce actual heart events. And at higher doses betaine can raise cholesterol and triglycerides — the opposite of what you'd want. So "lowering a number" doesn't equal a heart benefit here. Nikrandt G, Chmurzynska A. J Nutr. 2024. Open Source ↗

Why might betaine cause a fishy odor?

A mild fishy body or breath odor can come from how betaine is metabolized, usually at higher doses. Keeping the dose modest generally avoids it. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

Should I get betaine from food or a supplement?

Food is a sensible default — beets, spinach, and whole grains supply betaine naturally, with no risk of overdoing it. There's no official daily requirement, since betaine isn't an essential nutrient. Zeisel SH, et al. Concentrations of betaine in common foods. Open Source ↗

10. Choosing a Quality Product

Key Takeaway

Betaine is a simple, well-characterized ingredient. The main things to check are third-party testing (especially if you compete in sport) and a clearly labeled form and dose.

Supplement betaine is made from sugar beet and is a well-defined compound, so identity is rarely the issue. The key is buying from a reputable maker. U.S. Food and Drug Administration. Substances Added to Food: Betaine. Open Source ↗

What to Look For

Clear labeling: "betaine anhydrous (TMG)" and the amount per serving
The right form: anhydrous/monohydrate for the methyl-donor use (not betaine HCl, which is for stomach acidity)
Third-party testing: USP, NSF, or an equivalent — especially important for athletes given the contamination caveat
A modest dose: around 2.5 g/day; higher amounts raise the chance of a cholesterol/triglyceride rise
Honest claims: be skeptical of products promising muscle, fat loss, or heart benefits

Betaine is hygroscopic (it draws in moisture), so keep it tightly closed and dry. The supplement is inexpensive; the prescription product is a different, regulated medicine. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗

11. Genes, Folate & Betaine

Key Takeaway

Betaine and folate are two routes the body uses to recycle homocysteine. Betaine matters most when folate is low — and it works hand-in-hand with choline, B12, and B6.

Your body has two ways to recycle homocysteine back into methionine: a folate/B12-dependent route and a folate-independent betaine route (run by an enzyme called BHMT in the liver and kidney). The two are cooperative and partly cover for each other. In studies, betaine matters most for homocysteine after a protein/methionine load — and especially when folate intake is low. Obeid R. The metabolic burden of methyl-donor deficiency. Open Source ↗

Because betaine is made from choline, the two are partly interchangeable methyl sources — getting enough choline spares betaine and vice versa. Adequate folate, B12, and B6 round out this network. This is why these nutrients are usually considered together rather than in isolation. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗

12. Where Betaine Comes From

Key Takeaway

Betaine isn't a traditional herbal remedy — it's a defined compound first identified in sugar beet in the 1800s, which is exactly how it got its name.

Betaine has no folk-medicine lineage. It's a chemical compound that was first isolated from sugar beet (Beta vulgaris) in the 19th century — and the beet is where the name comes from. Today "betaine" is a whole chemical class, with trimethylglycine (TMG) being the original member. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗

13. Story Behind the Science

Key Takeaway

From a beet-sugar by-product, to an understood methyl donor, to an approved medicine for a rare condition, to a much-hyped sports supplement — betaine's arc shows the gap between mechanism and proven benefit.

Betaine was discovered in sugar beet in the 1860s and, over the 20th century, was understood as a methyl donor and cell osmolyte. Its biggest validated milestone was approval as a prescription medicine for a rare inherited condition. U.S. Food and Drug Administration. Cystadane (betaine anhydrous) Prescribing Information. Open Source ↗

More recently, betaine became popular as a sports and "methylation" supplement. As the trials came in, a clear pattern emerged: a real effect on a blood marker, but little proof of benefit for the outcomes people actually care about — a useful reminder that an interesting mechanism is not the same as a proven result. Nikrandt G, Chmurzynska A. J Nutr. 2024. Open Source ↗

14. Lab Tests

Key Takeaway

Betaine predictably changes several lab values — it lowers homocysteine but raises methionine, sarcosine, and DMG. These are real shifts, not errors, but they can confuse results if you don't tell your provider you're taking it.

Betaine produces predictable changes in "methyl-metabolite" blood and urine tests: it lowers homocysteine but raises methionine, sarcosine, and dimethylglycine (DMG). These are true metabolic changes, not lab artifacts — but they can be misread if your provider doesn't know you take betaine. For example, a high sarcosine level could be mistaken for a separate inherited condition. So note any betaine use on lab requisitions for amino-acid panels. Holm PI, et al. Determination of betaine and dimethylglycine. Open Source ↗

Two practical notes: a blood betaine level is not a reliable measure of your betaine "status," and if you take higher doses it's reasonable to check cholesterol and triglycerides given the high-dose lipid signal. Olthof MR, et al. Effect of betaine on blood lipids. Open Source ↗

✓ Last Reviewed: June 2026

Betaine Anhydrous (TMG)

Technical Data

Clinical reference for healthcare professionals

CLINICAL SUMMARY

Betaine Anhydrous (TMG)

Betaine (trimethylglycine; PubChem CID 247) — a BHMT methyl donor (homocysteine → methionine) and renal-medullary osmolyte, and the oxidation product of choline. The same molecule is an FDA-approved prescription drug (Cystadane) for homocystinuria — a supervised, high-dose medical use distinct from supplementation. As a supplement, betaine reliably lowers homocysteine (a marker), but supplement-use outcomes (ergogenic, hepatic, cardiovascular) are weak or negative, and high doses raise LDL/triglycerides. Not an essential nutrient (no defined deficiency state).

Overall Evidence (supplement)

Limited

Primary Uses Studied

StrongHomocystinuria (prescription DRUG, not supplement) · approved; lowers homocysteine across genetic subtypes
ModerateHomocysteine lowering (marker) · dose-dependent in healthy adults; no proven outcome benefit
InsufficientSports / body composition · meta-analysis null; strength modest/inconsistent
InsufficientLiver fat · pivotal 12-month RCT negative despite animal promise
LimitedCardiovascular / metabolic · no event benefit; high-dose LDL/triglyceride rise

Standard Intake Range

Supplement (ergogenic): ~2.5 g/day, chronic (≥7 days)
Homocysteine-lowering (studied): ~1.5–6 g/day
Dietary intake: ~100–400 mg/day; no RDA (not an essential nutrient)
Prescription DRUG (homocystinuria): 6 g/day up to 20 g/day under specialist care — context only, not a supplement dose

Key Safety Flags

🟢 WELL TOLERATED at the ~2.5 g/day supplement dose; AEs predominantly mild/GI
🟢 NOT HEPATOTOXIC — no association with clinically apparent liver injury
🟠 CAUTION High dose (≥4–6 g/day) raises LDL cholesterol + triglycerides (the lipid caveat)
🟠 CAUTION GI intolerance; mild fishy body/breath odour; rare skin welts/hair loss
🟠 CAUTION Athletes — beet-derived products may carry higenamine (banned); use tested products
🟠 DRUG-CONTEXT Brain swelling from very high methionine occurs only in homocystinuria at prescription doses (reversible) — not a supplement-dose risk
🔴 DO NOT USE Hypersensitivity to betaine / excipients

Monitoring Quick-Ref

Lipids (LDL/triglycerides): at high-dose use, particularly with cardiovascular risk
Homocysteine: if it is the explicit target
No status biomarker: plasma betaine does not reflect betaine stores

⚠️ Lab Interference

Predictable metabolite shifts, not assay artifacts. Betaine lowers homocysteine and raises methionine (~5×), sarcosine (~11×), and dimethylglycine. These are true pharmacodynamic changes that can confound amino-acid/organic-acid panels if undisclosed — e.g., markedly elevated sarcosine could be misread as primary sarcosinaemia. Record betaine use on requisitions; plasma betaine is not a validated status assay.

Clinical bottom line: Betaine anhydrous (TMG) is a BHMT methyl donor / osmolyte and choline's oxidation product that reliably lowers homocysteine; the same molecule is an FDA-approved drug for homocystinuria (supervised, high-dose — distinct from supplementation). As a supplement, ergogenic and hepatic benefits are weak/negative (body-composition meta-analysis null; pivotal liver RCT negative), cardiovascular outcomes are unproven, and high doses raise LDL/triglycerides — so a robust marker effect has not translated into demonstrated benefit. Well tolerated at ~2.5 g/day and not hepatotoxic; the serious brain-swelling risk is confined to the drug context. WADA-permitted, with a beet-derived higenamine-contamination caveat. Pregnancy/lactation: P-3 / T-U (supplement doses unstudied). The one absolute reason to avoid it is hypersensitivity.

1. Identity & Forms

Key Takeaway

Betaine (trimethylglycine; CID 247, CAS 107-43-7; C₅H₁₁NO₂) is a zwitterion. Subject form = anhydrous (Rx + supplement). Distinct from betaine HCl (acidic, for gastric acidity) and from cocamidopropyl betaine (a cosmetic surfactant).

Common name	Betaine (trimethylglycine, TMG; glycine betaine)
Chemical class	Zwitterion (inner salt); modified amino acid
Molecular formula	C₅H₁₁NO₂
Molecular weight	117.15 g·mol⁻¹
CAS Registry	107-43-7
PubChem CID	247
ATC / DrugBank	A16AA06 / DB06756
Subject form	Betaine anhydrous (both Rx Cystadane and supplement)
Distinct from	Betaine HCl (acidic, for gastric acidity); cocamidopropyl betaine (cosmetic surfactant)
Appearance	White, granular, hygroscopic, highly water-soluble

Identity. Betaine — N,N,N-trimethylglycine (TMG), glycine betaine — is a zwitterionic (inner-salt) modified amino acid: a trimethylammonium cation with a carboxylate anion (C₅H₁₁NO₂; MW 117.15; CAS 107-43-7; CID 247; ATC A16AA06; DrugBank DB06756). It was the first betaine discovered, isolated from sugar beet. White, granular, hygroscopic, highly water-soluble. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗

Forms (clinically important). Betaine anhydrous (subject) is the water-free, pH-neutral systemic methyl donor/osmolyte — both the Rx form (Cystadane) and the supplement form. Betaine monohydrate is the hydrated equivalent. Betaine HCl is an acidic salt used as a source of gastric acid for low stomach acid — a different purpose, not the methyl-donor framing. Betaine citrate/aspartate are historical liver-support salts. Not to be confused with cocamidopropyl betaine (an unrelated cosmetic surfactant). LiverTox (NIH). Betaine. Open Source ↗

2. Mechanism of Action

Key Takeaway

Two roles: (1) methyl donor — BHMT remethylates homocysteine to methionine (yielding DMG), a folate-independent backup to the methionine-synthase route; (2) organic osmolyte (renal medulla, via BGT1). Betaine is the oxidation product of choline.

Methyl donor. In the methionine cycle, homocysteine is remethylated by two routes: the ubiquitous folate/B12-dependent methionine synthase, and the folate-independent betaine–homocysteine methyltransferase (BHMT) — a cytosolic zinc metalloenzyme confined mainly to liver and kidney that transfers a methyl group from betaine to homocysteine, yielding methionine + dimethylglycine (DMG). The BHMT route is a major hepatic/renal contributor and a backup when the folate/B12 route is limited — the rationale for betaine's homocystinuria indication. Downstream, DMG → sarcosine → glycine, and SAM/DMG feedback-inhibit BHMT. Obeid R. The metabolic burden of methyl-donor deficiency. Open Source ↗

Organic osmolyte. Betaine is a compatible osmolyte that accumulates intracellularly (notably in the renal medulla) via the Na⁺/Cl⁻-dependent betaine/GABA transporter BGT1 (SLC6A12) to defend cell volume under osmotic stress, while stabilizing protein structure. Endogenously, betaine is the oxidation product of choline; it is not classically an essential nutrient (no defined deficiency state). LiverTox (NIH). Betaine. Open Source ↗

3. Pharmacokinetics (ADME)

Key Takeaway

Rapid, extensive oral absorption (Tmax ~1 h); endogenous plasma betaine ~0.1 mmol/L; concentrated in liver/kidney; metabolized (not excreted intact) to DMG → sarcosine → glycine; long terminal half-life (~14 h) that lengthens with repeated dosing. Poor brain access.

Absorption & distribution. Oral betaine is rapidly and extensively absorbed from the small intestine (Tmax ~1 h) with high bioavailability; endogenous plasma betaine is ~0.1 mmol/L, concentrated in the principal BHMT tissues (liver, kidney). It poorly accesses brain parenchyma (low BGT1 there). Schwahn BT, et al. Pharmacokinetics of oral betaine. Open Source ↗

Metabolism & elimination. Betaine is metabolized rather than excreted intact — donating a methyl group via BHMT to become DMG, then sarcosine → glycine. The terminal half-life is long (on the order of ~14 h) and lengthens with repeated dosing (tissue accumulation), consistent with a conserved osmolyte/methyl reserve; filtered betaine is largely reabsorbed. Obeid R. The metabolic burden of methyl-donor deficiency. Open Source ↗

4. Organ System Effects

Key Takeaway

Renal (osmolyte — central) and hepatic (BHMT methyl metabolism; not hepatotoxic; negative NASH RCT) effects dominate. Cardiovascular: lowers homocysteine but raises LDL/triglycerides + PAI-1 at high dose. Musculoskeletal: modest/inconsistent. Poor CNS access.

System	Effect	Notes
Renal (central)	Renal-medullary osmolyte	Cell-volume defense against urea / NaCl
Hepatic	Chief BHMT tissue; methyl metabolism	Protective in animal liver-fat models, but the human liver-fat RCT was negative; not liver-toxic
Cardiovascular	Lowers homocysteine; raises LDL/triglycerides + PAI-1 at high dose	The high-dose lipid signal is the stand-out concern
Musculoskeletal	Ergogenic interest	Modest / inconsistent
CNS	Poor access	Limited central effect

Renal & hepatic. Betaine is a principal renal-medullary osmolyte (cell-volume defense against urea/NaCl). The liver is the chief BHMT tissue; betaine is hepatoprotective in animal steatosis models but the human liver-fat RCT was negative, and BHMT activity is reduced in advanced liver scarring (contributing to elevated homocysteine). Notably, betaine is not hepatotoxic. LiverTox (NIH). Betaine. Open Source ↗ Abdelmalek MF, et al. Betaine for liver fat: a randomized placebo-controlled trial. Hepatology. 2009. Open Source ↗

Cardiovascular, musculoskeletal & CNS. Cardiovascular: lowers homocysteine (marker) but raises LDL/triglycerides and PAI-1 at high doses; net effect unsettled. Musculoskeletal: modest/inconsistent strength signals with proposed cell-hydration/creatine-synthesis rationales. CNS: poor brain access; the only serious neurologic event (brain swelling from very high methionine) is confined to homocystinuria at prescription doses. Olthof MR, et al. Effect of betaine on blood lipids. Open Source ↗

5. Dosing (Drug vs Supplement)

Key Takeaway

Supplement: ~2.5 g/day (ergogenic) or ~1.5–6 g/day (homocysteine). DRUG (homocystinuria): 6–20 g/day, titrated to homocysteine under specialist care with methionine monitoring — context only, not a supplement regimen. Dietary intake ~100–400 mg/day.

Context	Amount	Notes
Dietary intake	~100–400 mg/day	No RDA (not an essential nutrient)
Supplement — ergogenic	~2.5 g/day	Effects require chronic use (≥7 days)
Supplement — homocysteine	~1.5–6 g/day	Dose-dependent
Prescription (Cystadane, context only)	6 g/day (3 g twice daily), up to 20 g/day	Titrated to plasma homocysteine under specialist care
Monitoring	Lipids for high-dose users	High-dose LDL/triglyceride signal

5A. Supplement Dosing

Ergogenic: ~2.5 g/day; effects (such as they are) require chronic use (≥7 days).
Homocysteine-lowering: dose-dependent across ~1.5–6 g/day.
Dietary intake: ~100–400 mg/day; no RDA (not an essential nutrient).
Monitoring: none routine, but high-dose users with cardiovascular risk warrant lipid monitoring (high-dose LDL/triglyceride signal). Olthof MR, et al. Effect of betaine on blood lipids. Open Source ↗

5B. Prescription Drug Dosing (context only)

Homocystinuria (Cystadane): usual 6 g/day (3 g twice daily), titrated to plasma homocysteine; up to 20 g/day in some patients; pediatric initiation ~100 mg/kg/day. Biochemical response usually within ~1 week.
No added homocysteine benefit above ~100 mg/kg/day; higher doses chiefly raise methionine/SAM. Monitor plasma methionine (keep < 1000 µmol/L) to avoid the brain-swelling risk. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

This drug dosing is provided to distinguish supervised medical use from supplementation — it is not guidance for supplement users.

6. Clinical Evidence

Key Takeaway

Homocystinuria (drug): established. Homocysteine-lowering (marker): consistent. Sports/body composition: meta-analysis null. Liver: pivotal RCT negative. Cardiovascular outcomes: unproven, with a high-dose lipid-raising signal.

Homocystinuria (established — prescription DRUG). Betaine anhydrous is approved to lower homocysteine across genetic subtypes (CBS, MTHFR, cobalamin defects), with biochemical response usually within a week. This is a supervised, high-dose medical use — not a supplement indication. U.S. Food and Drug Administration. Cystadane (betaine anhydrous) Prescribing Information. Open Source ↗

Homocysteine lowering in healthy adults (marker). Betaine lowers plasma homocysteine dose-dependently; however, homocysteine-lowering has not been shown to reduce cardiovascular events. McRae MP. Betaine and plasma homocysteine: a meta-analysis. Open Source ↗

Sports / body composition (mixed/weak) & liver (negative). A systematic review and meta-analysis found betaine fails to improve body composition; strength effects are modest/inconsistent. For the liver, a 12-month placebo-controlled RCT (20 g/day) in biopsy-proven liver fat showed no significant histologic benefit despite animal hepatoprotection. Ashtary-Larky D, et al. Br J Nutr. 2022. Open Source ↗ Abdelmalek MF, et al. Betaine for liver fat: a randomized placebo-controlled trial. Hepatology. 2009. Open Source ↗

Cardiovascular / metabolic (unsettled; lipid caveat). No demonstrated cardiovascular-outcome benefit; higher-dose betaine (≥4–6 g/day) raises LDL cholesterol and triglycerides in pooled randomized data — a critical review characterized the field as marketing outpacing evidence. Nikrandt G, Chmurzynska A. J Nutr. 2024. Open Source ↗

7. Pharmacogenomics & Genetics

Key Takeaway

BHMT (zinc metalloenzyme) and the folate/MTHFR route are complementary. Plasma betaine is the stronger determinant of post-methionine-load homocysteine, especially when folate is low. Betaine and choline are interchangeable methyl sources.

Betaine's clinical role is shaped by the folate/one-carbon network. The BHMT (betaine) and methionine-synthase (folate/B12) remethylation routes are complementary: in cohort data, plasma betaine is the stronger determinant of post-methionine-load homocysteine — particularly in low-folate individuals — whereas folate dominates fasting homocysteine. Folic acid supplementation spares betaine as a methyl donor, and betaine and choline are interchangeable methyl sources (choline is oxidized to betaine). SAM and DMG feedback-inhibit BHMT, a built-in brake on incremental methyl-donor activity at very high doses. Obeid R. The metabolic burden of methyl-donor deficiency. Open Source ↗

8. Adverse Effects

Key Takeaway

Dose-related; mostly mild GI at supplement doses. Stand-out supplement concern = high-dose LDL/triglyceride rise. Not hepatotoxic; low acute toxicity; negative genotoxicity. The serious brain-swelling event is confined to homocystinuria at prescription doses (reversible).

Effect	Context	Notes
Stomach upset (nausea, diarrhea, bloating, cramps)	Most common	Dose-related
Raised LDL cholesterol / triglycerides	High supplement doses	Stand-out supplement concern
Fishy body / breath odour	Higher doses	Trimethylamine-related
Skin welts, hair loss	Reported	—
Increased urination	Reported	—
Mood or sleep changes (irritability, disturbed sleep)	Postmarketing	—
Brain swelling	Rx homocystinuria doses only	Reversible; not seen at supplement doses

Dose-context profile. At the ~2.5 g/day supplement dose betaine is generally very well tolerated; most labelled AEs derive from the 6–20 g/day drug range. By system: GI (most common — nausea, diarrhea, bloating, cramps); metabolism (very high methionine in the drug context; raised LDL cholesterol/triglycerides at high supplement doses); skin/general (mild fishy body/breath odour, skin welts, hair loss); renal/urinary (increased urination); plus postmarketing reports of mood or sleep changes (e.g., irritability, disturbed sleep). European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

Serious events & reassurances. The one serious event — brain swelling from very high methionine — occurred exclusively in homocystinuria (CBS) patients at prescription doses and resolves on discontinuation; a single drug-related interstitial lung disease case appears in a treatment registry. Reassuringly, betaine is not associated with liver injury, has low acute toxicity, and shows negative genotoxicity testing; no new safety signal was identified on pharmacovigilance review. LiverTox (NIH). Betaine. Open Source ↗

9. Drug Interactions

Key Takeaway

Few documented interactions. Space betaine ~30 min from amino-acid mixtures/vigabatrin (BGT1 competition); additive methionine with methionine-raising agents/diet; folate-route impairers shift remethylation onto betaine. Cooperative with folate/B12/B6/choline. Not a nutrient depleter; WADA-permitted (higenamine-contamination caveat).

9A. By Mechanism

Drugs. Amino-acid mixtures & vigabatrin/GABA analogues: product information advises ~30-minute spacing (no interaction studies; plausible BGT1 transporter competition). Methionine-raising agents / high-methionine load: additive methionine elevation (clinically relevant in the drug context). Folate/B12-route impairers (e.g., nitrous oxide, methotrexate): shift homocysteine remethylation onto the betaine/BHMT route, increasing betaine's relative importance (mechanistic). Few documented clinical interactions overall. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗

Nutrients & anti-doping. Folate/B12/B6 are cooperative (co-administered in homocystinuria; folic acid spares betaine); choline is interchangeable; the betaine+creatine sports stack is mechanistically rationalized but inconsistent. Betaine is not on the WADA Prohibited List and is not in the Monitoring Program; however, beet-derived products can be contaminated with higenamine (a banned β₂-agonist) — athletes should use third-party-tested products under strict liability. EFSA NDA Panel. Safety of betaine as a novel food. Open Source ↗

9B. Herb–Drug Interaction & Drug-Nutrient Depletion Table

Betaine is a nutrient/methyl donor and is not a nutrient depleter; the table summarizes the clinically relevant interactions.

Agent / class	Interaction & evidence	Action
Amino-acid mixtures; vigabatrin	Possible BGT1 transporter competition (no interaction studies)	Separate doses by ~30 minutes
Methionine supplements / high-methionine diet	Additive methionine elevation (drug-context relevance)	Avoid stacking; relevant in homocystinuria
Folate/B12-route impairers (nitrous oxide, methotrexate)	Shift remethylation onto betaine/BHMT route (mechanistic)	Awareness; ensure folate/B12 adequacy
Folate / B12 / B6 (nutrients)	Cooperative; folic acid spares betaine	Co-adequacy beneficial
Choline (nutrient)	Interchangeable methyl source (choline → betaine)	Context for methyl economy
Creatine	Theoretical synergy (SAM-dependent creatine synthesis); inconsistent	No reliable added benefit
Dietary nutrients	No depletion caused by betaine	Betaine is not a depleter

10. Cautions and Considerations

Key Takeaway

One absolute reason to avoid: hypersensitivity. Relative cautions: high-dose lipid rise, reduced kidney/liver function, athlete contamination, and the supervised-care context of homocystinuria. Pregnancy/lactation: P-3 / T-U.

10A. Cautions by Population

Hypersensitivity: the one absolute reason to avoid it — do not use.
Cardiovascular / lipid risk: high-dose betaine raises LDL/triglycerides — monitor lipids; keep doses modest.
Renal impairment: dimethylglycine accumulates in kidney failure; betaine handling is altered — use with guidance.
Hepatic impairment: BHMT is reduced in advanced liver scarring; betaine is not hepatotoxic, but the human liver-fat RCT was negative.
Homocystinuria: a supervised medical situation — methionine monitoring and the brain-swelling risk apply at prescription doses; not an OTC-supplement scenario.
Athletes: beet-derived higenamine-contamination caveat — use tested products.

10B. Pregnancy & Lactation

P-3 — Insufficient controlled data (precautionary) Lactation transfer: T-U (unstudied for supplementation)

Pregnancy: controlled trials of supplement-dose betaine in pregnancy are lacking. In homocystinuria, betaine is continued only when clearly necessary under specialist monitoring and appears compatible with good outcomes, with no specific malformation signal in postmarketing data — but that is the drug context. Supplement use should be deferred to the obstetric team. Lactation: betaine is endogenously present in breast milk, but supplementation safety/transfer is essentially unstudied (a milk-betaine PK study is ongoing). Route to an IBCLC/lactation consultant and pediatrician; LactMed is the appropriate reference. European Medicines Agency. Cystadane EPAR — Product Information. Open Source ↗ Centers for Disease Control and Prevention. Breastfeeding & Medications. Open Source ↗

Routing: pregnancy questions → obstetrician/midwife; lactation/infant-exposure → IBCLC/pediatrician; methylation or homocysteine questions → the relevant specialist (e.g., metabolic clinic or registered dietitian).

11. Synergies & Co-Nutrients

Key Takeaway

Cooperative with folate/B12/B6 and interchangeable with choline in the one-carbon network. Avoid stacking with supplemental methionine/high-protein loads, and avoid high doses where lipid-lowering is the goal.

11A. Positive / Cooperative

Folate / B12 / B6: cooperative remethylation; routinely co-administered in homocystinuria; folic acid spares betaine.
Choline: interchangeable methyl source (choline → betaine); see the Choline monograph.
Creatine: SAM-dependent creatine synthesis is the rationale for the betaine + creatine stack — theoretical and inconsistent.

11B. Combinations to Approach with Caution

Supplemental methionine / high-protein load — additive methionine (drug-context relevance).
High-dose betaine when lipid-lowering is the goal — the high-dose LDL/triglyceride signal is counterproductive.
Amino-acid mixtures / vigabatrin — separate by ~30 minutes.

Obeid R. The metabolic burden of methyl-donor deficiency. Open Source ↗

12. Lab Monitoring

Key Takeaway

Track homocysteine if it's the target and lipids at high doses. Expect predictable metabolite shifts (↓homocysteine; ↑methionine ~5×, sarcosine ~11×, DMG) that can confound amino-acid panels if undisclosed. Plasma betaine is not a status marker.

12A. Monitoring

For supplement users, routine monitoring is generally unnecessary, with two exceptions: check lipids (LDL/triglycerides) in high-dose users (especially with cardiovascular risk), and track homocysteine if it is the explicit target. Plasma betaine is not a validated status biomarker. In the drug context, plasma methionine is the safety marker (keep < 1000 µmol/L). Holm PI, et al. Determination of betaine and dimethylglycine. Open Source ↗

12B. Lab Interference

Test	Direction	Mechanism / note
Plasma total homocysteine	Decreased	BHMT remethylation — the intended marker effect
Plasma methionine	Increased (~5×)	Product of remethylation; safety marker in the drug context
Sarcosine	Increased (~11×)	Downstream of DMG; can be misread as primary sarcosinaemia if betaine use is undisclosed
Dimethylglycine (DMG)	Increased	Direct by-product; accumulates in kidney failure
Betaine status assay	—	Plasma betaine does not reflect betaine stores; no validated status test

13. Historical Context

Key Takeaway

No traditional-medicine lineage — betaine is a defined compound isolated from sugar beet in the 1860s, later approved as a prescription drug, and more recently popularized (and over-marketed) as a supplement.

Betaine has no folk-medicine tradition; it is a defined chemical first isolated from sugar beet (Beta vulgaris) in the 1860s, from which it takes its name. Its 20th-century characterization established the methyl-donor and osmolyte roles; its principal validated milestone was approval as a prescription medicine for a rare inherited condition. Its later popularity as a sports/"methylation" supplement outpaced the supporting evidence. PubChem (NIH). Compound Summary: Betaine (CID 247). Open Source ↗

14. Quality Control

Key Takeaway

Manufactured from sugar-beet molasses; well-defined. Verify form (anhydrous/monohydrate vs HCl), USP/grade, and third-party testing — the higenamine-contamination caveat makes tested products important for athletes. Hygroscopic — store dry.

Specification & manufacturing. Supplement betaine is recovered from sugar-beet molasses and is a well-defined compound; specify the form (anhydrous or monohydrate for the methyl-donor use, distinct from betaine HCl), with USP/grade material and third-party identity/purity testing. The beet-derived higenamine-contamination caveat makes third-party testing particularly important for competitive athletes. Betaine is hygroscopic, so moisture-controlled storage matters. U.S. Food and Drug Administration. Substances Added to Food: Betaine. Open Source ↗

Cost & positioning. Supplement-grade betaine is inexpensive; the prescription product (Cystadane) is a separate, regulated medicine at a different price point. Choose the form to match the intended use, and don't substitute a supplement for prescribed care. LiverTox (NIH). Betaine. Open Source ↗

✓ Last Reviewed: June 2026